Logo image of S

SENTINELONE INC -CLASS A (S) Stock Fundamental Analysis

NYSE:S - US81730H1095 - Common Stock

18.86 USD
+1.25 (+7.1%)
Last: 8/29/2025, 8:04:01 PM
18.7212 USD
-0.14 (-0.74%)
After Hours: 8/29/2025, 8:04:01 PM
Fundamental Rating

4

S gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 281 industry peers in the Software industry. The financial health of S is average, but there are quite some concerns on its profitability. S is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year S was profitable.
In the past year S had a positive cash flow from operations.
In the past 5 years S always reported negative net income.
In the past 5 years S reported 4 times negative operating cash flow.
S Yearly Net Income VS EBIT VS OCF VS FCFS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B -10B

1.2 Ratios

With a Return On Assets value of -17.89%, S is not doing good in the industry: 69.75% of the companies in the same industry are doing better.
With a Return On Equity value of -27.58%, S is not doing good in the industry: 60.14% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -17.89%
ROE -27.58%
ROIC N/A
ROA(3y)-14.45%
ROA(5y)-15.84%
ROE(3y)-20.46%
ROE(5y)-23.39%
ROIC(3y)N/A
ROIC(5y)N/A
S Yearly ROA, ROE, ROICS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 200 300

1.3 Margins

The Gross Margin of S (74.83%) is better than 66.19% of its industry peers.
In the last couple of years the Gross Margin of S has grown nicely.
The Profit Margin and Operating Margin are not available for S so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y4.22%
S Yearly Profit, Operating, Gross MarginsS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

6

2. Health

2.1 Basic Checks

S does not have a ROIC to compare to the WACC, probably because it is not profitable.
S has more shares outstanding than it did 1 year ago.
The number of shares outstanding for S has been increased compared to 5 years ago.
S has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
S Yearly Shares OutstandingS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
S Yearly Total Debt VS Total AssetsS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

S has an Altman-Z score of 3.54. This indicates that S is financially healthy and has little risk of bankruptcy at the moment.
S's Altman-Z score of 3.54 is fine compared to the rest of the industry. S outperforms 61.21% of its industry peers.
S has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.54
ROIC/WACCN/A
WACC11.24%
S Yearly LT Debt VS Equity VS FCFS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B 30B

2.3 Liquidity

S has a Current Ratio of 1.75. This is a normal value and indicates that S is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of S (1.75) is comparable to the rest of the industry.
S has a Quick Ratio of 1.75. This is a normal value and indicates that S is financially healthy and should not expect problems in meeting its short term obligations.
S has a Quick ratio (1.75) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.75
S Yearly Current Assets VS Current LiabilitesS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

8

3. Growth

3.1 Past

S shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 350.00%, which is quite impressive.
The Revenue has grown by 32.25% in the past year. This is a very strong growth!
The Revenue has been growing by 77.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)32.25%
Revenue growth 3Y58.89%
Revenue growth 5Y77.59%
Sales Q2Q%21.74%

3.2 Future

The Earnings Per Share is expected to grow by 84.57% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 22.16% on average over the next years. This is a very strong growth
EPS Next Y301.17%
EPS Next 2Y163.78%
EPS Next 3Y111.46%
EPS Next 5Y84.57%
Revenue Next Year22.07%
Revenue Next 2Y21.48%
Revenue Next 3Y20.4%
Revenue Next 5Y22.16%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
S Yearly Revenue VS EstimatesS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
S Yearly EPS VS EstimatesS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 1 2

3

4. Valuation

4.1 Price/Earnings Ratio

S is valuated quite expensively with a Price/Earnings ratio of 188.60.
Compared to the rest of the industry, the Price/Earnings ratio of S is on the same level as its industry peers.
S is valuated expensively when we compare the Price/Earnings ratio to 27.08, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 54.21 indicates a quite expensive valuation of S.
S's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.72. S is valued rather expensively when compared to this.
Industry RankSector Rank
PE 188.6
Fwd PE 54.21
S Price Earnings VS Forward Price EarningsS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of S is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 342.07
EV/EBITDA N/A
S Per share dataS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

S's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
S's earnings are expected to grow with 111.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.63
PEG (5Y)N/A
EPS Next 2Y163.78%
EPS Next 3Y111.46%

0

5. Dividend

5.1 Amount

No dividends for S!.
Industry RankSector Rank
Dividend Yield N/A

SENTINELONE INC -CLASS A

NYSE:S (8/29/2025, 8:04:01 PM)

After market: 18.7212 -0.14 (-0.74%)

18.86

+1.25 (+7.1%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-28 2025-08-28/amc
Earnings (Next)12-02 2025-12-02/amc
Inst Owners80.1%
Inst Owner Change0.17%
Ins Owners0.56%
Ins Owner Change4.97%
Market Cap6.27B
Analysts79.11
Price Target23.41 (24.13%)
Short Float %4.18%
Short Ratio1.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)98.91%
Min EPS beat(2)23.01%
Max EPS beat(2)174.81%
EPS beat(4)3
Avg EPS beat(4)106.86%
Min EPS beat(4)-100%
Max EPS beat(4)329.6%
EPS beat(8)7
Avg EPS beat(8)86.09%
EPS beat(12)11
Avg EPS beat(12)64.14%
EPS beat(16)14
Avg EPS beat(16)45.16%
Revenue beat(2)0
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)-0.52%
Revenue beat(4)0
Avg Revenue beat(4)-1.23%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)-0.52%
Revenue beat(8)4
Avg Revenue beat(8)0.45%
Revenue beat(12)6
Avg Revenue beat(12)0.46%
Revenue beat(16)10
Avg Revenue beat(16)2.26%
PT rev (1m)-0.12%
PT rev (3m)-6.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.1%
EPS NY rev (1m)0.05%
EPS NY rev (3m)5.27%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-1.19%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.26%
Valuation
Industry RankSector Rank
PE 188.6
Fwd PE 54.21
P/S 7.26
P/FCF 342.07
P/OCF 142.52
P/B 4.05
P/tB 7.68
EV/EBITDA N/A
EPS(TTM)0.1
EY0.53%
EPS(NY)0.35
Fwd EY1.84%
FCF(TTM)0.06
FCFY0.29%
OCF(TTM)0.13
OCFY0.7%
SpS2.6
BVpS4.65
TBVpS2.45
PEG (NY)0.63
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.89%
ROE -27.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.83%
FCFM 2.12%
ROA(3y)-14.45%
ROA(5y)-15.84%
ROE(3y)-20.46%
ROE(5y)-23.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y4.22%
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 59.8%
Cap/Sales 2.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.75
Altman-Z 3.54
F-Score5
WACC11.24%
ROIC/WACCN/A
Cap/Depr(3y)58.32%
Cap/Depr(5y)105.17%
Cap/Sales(3y)3.59%
Cap/Sales(5y)4.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y301.17%
EPS Next 2Y163.78%
EPS Next 3Y111.46%
EPS Next 5Y84.57%
Revenue 1Y (TTM)32.25%
Revenue growth 3Y58.89%
Revenue growth 5Y77.59%
Sales Q2Q%21.74%
Revenue Next Year22.07%
Revenue Next 2Y21.48%
Revenue Next 3Y20.4%
Revenue Next 5Y22.16%
EBIT growth 1Y1.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year308.78%
EBIT Next 3Y93.58%
EBIT Next 5Y62.03%
FCF growth 1Y109.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y125.58%
OCF growth 3YN/A
OCF growth 5YN/A